<DOC>
	<DOCNO>NCT00861003</DOCNO>
	<brief_summary>This prospective study examines difference among several measure adherence antipsychotic medication outpatient schizophrenia . Adherence assess use self-report , physician report , pill count electronic monitoring . The rate adherence/non-adherence various tool manifest . The association antipsychotic adherence/non-adherence various clinical status , include psychotic symptom , depressive symptom , side effect , neurocognitive function insight analyze . Participants assess baseline visit outpatient clinic follow 8 week .</brief_summary>
	<brief_title>An Adherence Study Antipsychotic Medication Outpatients With Schizophrenia Schizoaffective Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>1 . Ability provide write informed consent 2 . Male female , age 20 65 year 3 . Clinician render diagnosis schizophrenia schizoaffective disorder document checklist Diagnostic Statistical Manual Mental Disorders Fourth Edition ( DSMIV ) criteria 4 . Currently take single oral antipsychotic ( e.g. , Quetiapine , Risperidone , Olanzapine , Amisulpride ) . 5 . Female patient childbearing potential must use reliable method contraception negative urine human chorionic gonadotropine ( HCG ) test enrolment 6 . Outpatient status , psychiatric hospitalization psychiatric emergency room visit within previous 2 year hospitalization within 3 month 7. mild moderate symptom check CGIS ( less score 4 ) 8 . Able understand comply requirement study 1 . Any DSMIV Axis I disorder define inclusion criterion 2 . Presence comorbid diagnosis might influence outcome measure ( e.g. , mental retardation ) 3 . Alcohol substance dependence enrolment ( except dependence full remission , except caffeine nicotine dependence ) , define DSMIV criterion 4 . Patients , opinion investigator , pose imminent risk suicide danger self others 5 . Pregnancy lactation 6 . Evidence hypersensitivity Quetiapine antipsychotic use study 7 . Use cytochrome P450 inhibitor inducer 14 day precede enrolment 8 . Administration depot antipsychotic injection within one dose interval ( depot ) randomisation 9. use pillbox 10 . Treatment Clozapine ( unique monitoring guideline ) 11 . Administration electroconvulsive therapy ( ECT ) last 6 month 12 . Unstable inadequately treat medical condition heart , liver , kidney , lung disease , seizure disorder 13 . Involvement plan conduct study . 14 . Participation another drug trial within 4 week prior enrolment study long accordance local requirement .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>adherence</keyword>
</DOC>